CWM
DNTH icon

Crowley Wealth Management’s Dianthus Therapeutics DNTH Stock Holding History

Crowley Wealth Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-221
Closed -$8.7K – 100
2025
Q3 		$8.7K Hold
221
– – 0.01% 294
2025
Q2 		$4.12K Hold
221
– – ﹤0.01% 312
2025
Q1 		$4.01K Hold
221
– – ﹤0.01% 313
2024
Q4 		$4.82K Buy
+221
New +$5.68K ﹤0.01% 311

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crowley Wealth Management's DNTH Position: Q4 2025 in Review

Crowley Wealth Management sold out of Dianthus Therapeutics (DNTH) in Q4 2025, closing a stake of 221 shares — an estimated $8.7K sold.

Crowley Wealth Management first reported a position in DNTH in Q4 2024 and held it in 4 quarters. The position peaked at $8.7K in Q3 2025. 165 funds tracked by Wall St. Rank hold DNTH as of Q4 2025.

  • Crowley Wealth Management reported no remaining Dianthus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Crowley Wealth Management sold 221 Dianthus Therapeutics shares in Q4 2025, an estimated $8.7K.
  • Crowley Wealth Management first reported a position in Dianthus Therapeutics in Q4 2024 and held it in 4 quarters.
  • Crowley Wealth Management's Dianthus Therapeutics position peaked at $8.7K in Q3 2025.
  • 165 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q4 2025.

Based on Crowley Wealth Management's 13F filing for Q4 2025.